v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Balances at Dec. 31, 2024 $ 13 $ 307,756 $ (200,482) $ 107,287
Balances (in Shares) at Dec. 31, 2024 129,012        
Issuance of shares related to stock option exercises
Issuance of shares related to stock option exercises (in Shares) 141        
Issuance of shares for cash $ 1 93,635 93,636
Issuance of shares for cash (in Shares) 8,163        
Issuance of shares related to exercise of warrants 12 12
Issuance of shares related to exercise of warrants (in Shares) 6        
Stock-based compensation 2,892 2,892
Stock-based compensation for services 18 18
Net (loss) income 16,982 16,982
Unrealized losses on available-for-sale debt securities        
Balances at Mar. 31, 2025 $ 14 404,313 (183,500) 220,827
Balances (in Shares) at Mar. 31, 2025 137,322        
Balances at Dec. 31, 2024 $ 13 307,756 (200,482) 107,287
Balances (in Shares) at Dec. 31, 2024 129,012        
Balances at Dec. 31, 2025 $ 22 1,816,494 (219,156) 905 1,598,265
Balances (in Shares) at Dec. 31, 2025 224,165        
Issuance of shares related to stock option exercises $ 1 3,506 3,507
Issuance of shares related to stock option exercises (in Shares) 856        
Shares released from escrow relating to settled litigation - see Note 10
Shares released from escrow relating to settled litigation - see Note 10 (in Shares) 100        
Equity consideration for acquisition 2,038 2,038
Stock-based compensation 1,246 1,246
Stock-based compensation (in Shares) 373        
Net (loss) income (4,050) (4,050)
Unrealized losses on available-for-sale debt securities (3,822) (3,822)
Balances at Mar. 31, 2026 $ 23 $ 1,823,284 $ (223,206) $ (2,917) $ 1,597,184
Balances (in Shares) at Mar. 31, 2026 225,494